NASDAQ:SCMP

(SCMP) (SCMP) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
$18.00
$18.00
50-Day Range
$18.00
$18.00
52-Week Range
$9.30
$18.75
Volume
303,068 shs
Average Volume
2.56 million shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
SCMP stock logo

About (SCMP) Stock (NASDAQ:SCMP)

Sucampo Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of pharmaceutical products. Its primary focus areas are gastroenterology, ophthalmology and oncology-related disorders. Its product candidates include VTS-270, Lubiprostone (AMITIZA), Unoprostone is opropyl (RESCULA) and CPP-1X/sulindac combination product. VTS-270 is an investigational drug under clinical study for the treatment of Niemann-Pick Disease Type C-1, an ultra-orphan, progressive and fatal disease. AMITIZA is a ClC-2 chloride channel activator, which has been approved for three indications that cover distinct patient types: chronic idiopathic constipation, irritable bowel syndrome with constipation, and opioid-induced constipation. RESCULA is a Big Potassium channel activator used to lower intraocular pressure. CPP-1X/sulindac combination product is meant for the treatment of familial adenomatous polyposis (FAP).

SCMP Stock News Headlines

POTUS in ‘25 Not Biden/Trump, But
And I believe when they do take the oath of office, their fingers will be crossed… and America will descend into chaos.
POTUS in ‘25 Not Biden/Trump, But
And I believe when they do take the oath of office, their fingers will be crossed… and America will descend into chaos.
See More Headlines
Receive SCMP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for (SCMP) and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/01/2017
Today
5/01/2024

Industry, Sector and Symbol

Sector
N/A
Industry
N/A
Sub-Industry
Pharmaceuticals
Current Symbol
NASDAQ:SCMP
CUSIP
86490910
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
The Best High-Yield Dividend Stocks for 2024 Cover

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

Key Executives

  • Peter S. Greenleaf (Age 47)
    Chairman of the Board, Chief Executive Officer
  • Peter P. Pfreundschuh CPA (Age 48)
    Chief Financial Officer
  • Max Donley (Age 48)
    Executive Vice President of Global Human Resources, Information Technology and Strategy
  • Matthias Alder (Age 52)
    Executive Vice President
  • Peter A. Kiener Ph.D. (Age 64)
    Chief Scientific Officer
  • Alex Driggs (Age 41)
    General Counsel, Corporate Secretary
  • Peter Lichtlen M.D. (Age 47)
    Ph.D., Chief Medical Officer
  • John H. Johnson (Age 58)
    Lead Independent Director
  • Paul R. Edick (Age 62)
    Director
  • Daniel P. Getman Ph.D. (Age 59)
    Director

SCMP Stock Analysis - Frequently Asked Questions

How were (SCMP)'s earnings last quarter?

(SCMP) (NASDAQ:SCMP) released its quarterly earnings data on Wednesday, November, 1st. The biopharmaceutical company reported $0.27 earnings per share for the quarter, beating analysts' consensus estimates of $0.25 by $0.02. The biopharmaceutical company earned $61.27 million during the quarter, compared to the consensus estimate of $58.05 million. The firm's quarterly revenue was up 5.9% on a year-over-year basis. During the same period last year, the business posted $0.30 earnings per share.

What other stocks do shareholders of (SCMP) own?

Based on aggregate information from My MarketBeat watchlists, some companies that other (SCMP) investors own include XOMA (XOMA), SentinelOne (S), Alnylam Pharmaceuticals (ALNY), Teekay Tankers (TNK), Xenon Pharmaceuticals (XENE), Gilead Sciences (GILD), OPKO Health (OPK), Cisco Systems (CSCO), Infinera (INFN) and Micron Technology (MU).

This page (NASDAQ:SCMP) was last updated on 5/2/2024 by MarketBeat.com Staff

From Our Partners